BIOGEN IDEC INC. 4
4 · BIOGEN IDEC INC. · Filed Sep 18, 2013
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Pawlicki Raymond
SVP, Chief Information Officer
Transactions
- Sale
Common Stock
2013-09-16$238.03/sh−4,000$952,120→ 8,710.378 total - Exercise/Conversion
Common Stock
2013-09-16$49.59/sh+4,000$198,360→ 12,710.378 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-09-16−4,000→ 8,480 totalExercise: $49.59Exp: 2018-10-01→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock options vest in four (4) equal annual installments commencing one year after the grant date of 10/01/08.